A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young ...

Medistry LLC is the internet registry operator of the .med top level domain (TLD). Currently in a period of pre-registration ...

South Korean electronics giant Samsung has continued a push into the health category with an agreement to buy Xealth, a ...

So, what were the major themes to come out of BIO Boston 2025? Who’s getting excited about what? And – besides the obvious ...

Healthcare generates massive volumes of data daily – from electronic health records and insurance claims to genomic research ...

KalVista Pharma has finally received FDA approval for its oral kallikrein inhibitor sebetralstat, becoming the first ...

On the forefront of healthcare change, turning innovative science into value for patients: Astellas at ASCO 2025 At this year ...

Medical research charities LifeArc and Genetics Alliance UK have issued a call to the government to topple obstacles impeding ...

President Donald Trump took time out from the 4th July celebrations in the US to sign his One Big, Beautiful Bill Act (OBBBA) ...

J&J has rights to niraparib in prostate cancer, and views the drug as a successor to Zytiga, once a $2.5 billion-a-year ...

Hikma's announcement ties into that sentiment, coming with the strap line: "America Leans on Hikma: Quality Medicines ...

The first half of 2025 has been marked by a surge in strategic activity across the global healthcare, life sciences, and ...